Gene therapies have already been successfully implemented for spinal muscular atrophy (SMA1), and therapies for other neurodegenerative diseases, including AD, PD, ALS, FTD, and Huntington’s disease (HD), are currently under development [185,186]. This evidence concerns the gene SMN1 and juvenile Huntington disease.